Study of Chemosensory Enhancement through Neuromodulation Training (SCENT): Design and methodology of a randomized clinical trial for COVID-related persistent smell dysfunction
Post COVID persistent smell dysfunction and related deficits are relatively common with very few treatment options. Our proposed study will lay the groundwork for further development of ST and TNS as evidence-based treatments for Long COVID.
Authors
- Aicko Y. Schumann (ORCID: https://orcid.org/0000-0003-2583-1057)
- Lisa M. McTeague (ORCID: https://orcid.org/0000-0003-4475-9425)
- Thomas W. Uhde (ORCID: https://orcid.org/0000-0002-4197-9695)
- Rodney J. Schlosser (ORCID: https://orcid.org/0000-0001-6480-0275)
- Bernadette M. Cortese (ORCID: https://orcid.org/0000-0001-8456-7431)
- Bashar W. Badran (ORCID: https://orcid.org/0000-0001-9376-6440)
- Nicole Cash
- Mary Clare Koebel
Institutions
- Medical University of South Carolina (US)
- Ralph H. Johnson VA Medical Center (US)
Publication Details
- Journal
- Contemporary Clinical Trials Communications
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1016/j.conctc.2025.101582
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00